1-193122225-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024529.5(CDC73):c.25C>T(p.Arg9*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R9R) has been classified as Likely benign.
Frequency
Consequence
NM_024529.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hyperparathyroidism 2 with jaw tumorsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
- hyperparathyroidism 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- parathyroid gland carcinomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial isolated hyperparathyroidismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Parathyroid carcinoma Pathogenic:1
This premature translational stop signal has been observed in individual(s) with clinical features of CDC73-related conditions (PMID: 12434154). ClinVar contains an entry for this variant (Variation ID: 3268). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg9*) in the CDC73 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDC73 are known to be pathogenic (PMID: 12434154). -
Hyperparathyroidism 2 with jaw tumors Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R9* pathogenic mutation (also known as c.25C>T), located in coding exon 1 of the CDC73 gene, results from a C to T substitution at nucleotide position 25. This changes the amino acid from an arginine to a stop codon within coding exon 1. The predicted stop codon occurs within the first 150 nucleotides of CDC73 gene. This alteration may escape nonsense-mediated mRNAdecay and/or be rescued by re-initiation (Rivas et al. Science. 2015 May 8;348(6235):666-9; Lindeboom et al. Nat Genet. 2016 Oct;48(10):1112-8; Rhee et al. Sci Rep. 2017 May 10;7(1):1653). However, re-initiation on a downstream methionine would remove a significant portion of the protein. In addition, this mutation has been described in at least one family and one individual with hyperparathyroidism-jaw tumor syndrome (Carpten JD et al. Nat. Genet. 2002 Dec;32(4):676-80; Schmidt BP et al. J. Oral Maxillofac. Surg. 2009 Feb;67(2):423-7). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at